Skip to content

Enhancing Social Cognition training Program's Efficacy

A randomized controlled trial of enhanced efficacy of social cognition training for schizophrenia and autism spectrum disorders - EnSCoPE study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052584
Enrollment
60
Registered
2023-10-24
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia spectrum disorder, autism spectrum disorder

Interventions

Social cognition training plus cognitive remediation (group sessions of 1.5 hours once a week for 12 weeks) Social cognition training plus illness management training (group sessions of 1.5 hours once

Sponsors

Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet DSM-5 schizophrenia spectrum disorder and/or autism spectrum disoder criteria 2. WAIS-III estimated IQ of 65 or higher 3. Stable condiion and availability for continued participation in the study 4. Ability to communicate, read, and write in Japanese 5. Fully understand this study and provide written infromed consent

Exclusion criteria

Exclusion criteria: 1. Current substance or alcohol abuse 2. Traumatic head injury, cerebrovascular disease, or neurodegenerative disease 3. At high risk of violence, suicide attempts, or impulsive behavior

Design outcomes

Primary

MeasureTime frame
Changes in social cognitive functions (facial emotion recognition tasks) 12 weeks after the introduction of the intervention

Secondary

MeasureTime frame
Baseline (0w), post-intervention (12w), 12-week follow-up (24w), 1-year follow-up (64w): Social functioning (social outcome composite rating) General functioning (GAF) QOL (WHOQOL26) Clinical symptoms (SPQ, AQ, TAS-20) 0w, 12w, 24w: Neurocognition (MCCB) Clinical symptoms (BE-PSD-V2.0, CARS2-HF) Gaze behavior (eye tracking) 0w,12w: Brain imaging (structural and functional MRI)

Countries

Japan

Contacts

Public ContactSadao Otsuka

Graduate School of Medicine, Kyoto University Department of Psychiatry

scst.kyoto@gmail.com075-751-4947

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026